ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 163 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q1 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $406,012 | -31.4% | 16,674 | -4.8% | 0.00% | – |
Q1 2024 | $591,516 | +165.7% | 17,516 | +148.0% | 0.00% | – |
Q4 2023 | $222,665 | -9.1% | 7,062 | +37.4% | 0.00% | – |
Q3 2021 | $245,000 | +21.3% | 5,138 | -13.9% | 0.00% | – |
Q2 2021 | $202,000 | -9.8% | 5,970 | +10.2% | 0.00% | – |
Q1 2021 | $224,000 | -51.3% | 5,417 | -48.9% | 0.00% | – |
Q4 2020 | $460,000 | – | 10,610 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Portolan Capital Management | 484,907 | $11,807,485 | 0.97% |
Nikko Asset Management Americas, Inc. | 1,563,065 | $37,966,849 | 0.44% |
Diametric Capital, LP | 32,765 | $797,827 | 0.43% |
ARK Investment Management | 1,964,964 | $47,846,871 | 0.42% |
SummerHaven Investment Management, LLC | 23,400 | $569,790 | 0.38% |
Quantedge Capital Pte Ltd | 40,800 | $993,480 | 0.36% |
Granahan Investment Management | 344,549 | $8,389,768 | 0.34% |
FEDERATED HERMES, INC. | 4,694,060 | $114,300,361 | 0.27% |
Belmont Capital, LLC | 40,000 | $974,000 | 0.18% |
Woodline Partners LP | 754,023 | $18,360,460 | 0.18% |